Recently, we corrected sickle cell disease in a mouse model by transducing purified, unmobilized hematopoietic stem cells (HSCs) with a lentiviral vector carrying an anti-sickling beta-globin gene (betaAS3). Unlike previously reported studies, HSCs were purified from unmobilized marrow to model a transduction protocol that may be translated directly to human patients. Also, 1,000 times less virus was used compared to previous studies in an attempt to develop a safer transduction protocol. We propose to utilize this same protocol to transduce purified, human hematopoietic stem cells from sickle cell patients. Although this approach is powerful, one weakness is that the site of lentiviral integration cannot be determined before cells are transplanted back into the recipient. An approach that bypasses this potential problem is to transduce embryonic stem cells. Viral integration sites can then be sequenced in multiple colonies to define cells that contain insertions in innocuous positions in the genome. These cells can then be differentiated into hematopoietic stem cells and subsequently transplanted into recipients. We have recently corrected our mouse model of beta-thalassemia by lentiviral transduction of ES cells and we propose to do similar experiments in our mouse model of sickle cell disease. Finally, we have recently produced a new mouse model of sickle cell disease by replacing the mouse beta- globin genes with the human betaS gene and replacing the mouse alpha-globin genes with human alpha-globin genes in ES cells. Mice derived from these knockin modifications develop all of the pathology of our previous knockout, transgenic mouse model. We have now derived ES cells from these mice and propose to correct the sickle gene by homologous recombination. This protocol avoids random insertion. These cells will then be differentiated into HSCs and transplanted into irradiated sickle mouse recipients. Although this approach cannot be translated to humans at the present time, the studies will test the efficacy and safety of this protocol.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL057619-12
Application #
7629134
Study Section
Special Emphasis Panel (ZRG1-HEME-B (02))
Program Officer
Qasba, Pankaj
Project Start
1996-09-30
Project End
2010-01-06
Budget Start
2009-06-01
Budget End
2010-01-06
Support Year
12
Fiscal Year
2009
Total Cost
$445,682
Indirect Cost
Name
University of Alabama Birmingham
Department
Biochemistry
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Sun, Chiao-Wang; Wu, Li-Chen; Knopick, Peter L et al. (2017) Sickle cells produce functional immune modulators and cytotoxics. Am J Hematol 92:981-988
Chang, Chia-Wei; Lai, Yi-Shin; Lamb Jr, Lawrence S et al. (2014) Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells. PLoS One 9:e97335
Young, Margaret A; Larson, David E; Sun, Chiao-Wang et al. (2012) Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 10:570-82
Zhang, Zhuo; Jones, Amanda; Sun, Chiao-Wang et al. (2011) PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells 29:229-40
Isbell, T Scott; Sun, Chiao-Wang; Wu, Li-Chen et al. (2008) SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation. Nat Med 14:773-7
Hanna, Jacob; Wernig, Marius; Markoulaki, Styliani et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-3
Levasseur, Dana N; Ryan, Thomas M; Reilly, Michael P et al. (2004) A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin. J Biol Chem 279:27518-24
Levasseur, Dana N; Ryan, Thomas M; Pawlik, Kevin M et al. (2003) Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood 102:4312-9
Chen, W; Wu, X; Levasseur, D N et al. (2000) Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 18:352-9